JP2007513896A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513896A5
JP2007513896A5 JP2006543369A JP2006543369A JP2007513896A5 JP 2007513896 A5 JP2007513896 A5 JP 2007513896A5 JP 2006543369 A JP2006543369 A JP 2006543369A JP 2006543369 A JP2006543369 A JP 2006543369A JP 2007513896 A5 JP2007513896 A5 JP 2007513896A5
Authority
JP
Japan
Prior art keywords
ucl
receptor
pharmaceutical formulation
fub
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006543369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513896A (ja
JP2007513896A6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2004/000862 external-priority patent/WO2005056056A2/en
Publication of JP2007513896A publication Critical patent/JP2007513896A/ja
Publication of JP2007513896A6 publication Critical patent/JP2007513896A6/ja
Publication of JP2007513896A5 publication Critical patent/JP2007513896A5/ja
Withdrawn legal-status Critical Current

Links

JP2006543369A 2003-12-15 2004-12-14 セロトニン再取り込み阻害剤およびヒスタミン3受容体アンタゴニスト、インバースアゴニストまたはパーシャルアゴニストの併用 Withdrawn JP2007513896A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52949103P 2003-12-15 2003-12-15
DKPA200301854 2003-12-15
US60/529,491 2003-12-15
DKPA200301854 2003-12-15
PCT/DK2004/000862 WO2005056056A2 (en) 2003-12-15 2004-12-14 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist

Publications (3)

Publication Number Publication Date
JP2007513896A JP2007513896A (ja) 2007-05-31
JP2007513896A6 JP2007513896A6 (ja) 2007-09-06
JP2007513896A5 true JP2007513896A5 (cg-RX-API-DMAC7.html) 2008-01-17

Family

ID=34680191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006543369A Withdrawn JP2007513896A (ja) 2003-12-15 2004-12-14 セロトニン再取り込み阻害剤およびヒスタミン3受容体アンタゴニスト、インバースアゴニストまたはパーシャルアゴニストの併用

Country Status (6)

Country Link
EP (1) EP1696896A2 (cg-RX-API-DMAC7.html)
JP (1) JP2007513896A (cg-RX-API-DMAC7.html)
AU (1) AU2004296531A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0415899A (cg-RX-API-DMAC7.html)
NO (1) NO20063267L (cg-RX-API-DMAC7.html)
WO (1) WO2005056056A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG146683A1 (en) 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
US7728031B2 (en) 2006-02-24 2010-06-01 Abbott Laboratories Octahydro-pyrrolo[3,4-b]pyrrole derivatives
CN101809021B (zh) 2007-09-11 2013-04-24 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯n-氧化物
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
JP7579028B2 (ja) * 2020-12-23 2024-11-07 上海雲晟研新生物科技有限公司 ビラゾドン医薬組成物、その製造方法及び応用
AU2024230525A1 (en) * 2023-02-28 2025-10-09 Biohaven Therapeutics Ltd. Methods for treating obsessive compulsive related disorders, tic disorders and glutamate excitotoxicity related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020279A1 (en) * 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals
HK1040055B (zh) * 1998-05-22 2005-04-01 伊莱利利公司 奥氮平和氟西汀在制备治疗对抗治疗的严重抑郁症的药物中的应用
BR9911068A (pt) * 1998-05-29 2001-02-06 Lilly Co Eli Terapia combinada para tratamento de distúrbios bipolares
EP0978512A1 (en) * 1998-07-29 2000-02-09 Societe Civile Bioprojet Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications

Similar Documents

Publication Publication Date Title
JP2007513052A5 (cg-RX-API-DMAC7.html)
JP2009538331A5 (cg-RX-API-DMAC7.html)
JP2009538331A (ja) 抑うつ障害のための治療
JP2023100904A5 (cg-RX-API-DMAC7.html)
NO20063620L (no) Arylanilinderivater som beta2 adrenergiske receptoragonister
US6184218B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
RU2019143572A (ru) Композиции для лечения посттравматического стрессового расстройства
NO20081733L (no) Kontrollert frigjorende farmasoytisk sammensetning av venlafaksinhydroklorid og fremgangsmate for dens fremstilling
JP2007513052A (ja) セロトニン再取り込み阻害剤およびアゴメラチンの併用。
Nutt Beyond psychoanaleptics–can we improve antidepressant drug nomenclature?
JP2009542819A5 (cg-RX-API-DMAC7.html)
HRP20120713T1 (hr) Kombinacija analeptičkog modafinila i antidepresiva za liječenje depresije
CA2490638A1 (en) Combination therapy wherein a serotonin reuptake inhibitor is used
JP2007505156A5 (cg-RX-API-DMAC7.html)
WO2004100939B1 (en) Combination of the analeptic modafinil and an antidepressant for the treatment of depression
PE20061355A1 (es) Composicion farmaceutica que comprende ramelteon
WO2004100940B1 (en) Combination of the analeptic modafinil and an antidepressant for the treatment of depression
JP2009542820A5 (cg-RX-API-DMAC7.html)
UA84692C2 (ru) Фармацевтическая композиция, содержащая арипипразол и ингибитор повторного усвоения серотонина, и ее использование для лечения расстройств настоения
JP2007502785A5 (cg-RX-API-DMAC7.html)
WO2005056056A3 (en) The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
AR045314A1 (es) Composiciones farmaceuticas de analepticos y antidepresivos
AR048134A1 (es) La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
JP2007504181A (ja) セロトニン再取り込み阻害剤およびロキサピンの併用
CN1845730A (zh) 5-羟色胺再摄取抑制剂与克塞平的组合